Er-Kim Announces Exclusive Distribution Agreement with the MEDICE Health Family For Vafseo® in Central & Eastern Europe
14. Januar 2025 08:00 ET
|
Er-Kim
Er-Kim's partnership will support access of an alternative treatment to improve the lives of people impacted by anemia caused by chronic kidney disease
USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent
14. Januar 2025 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Groupe PAT : La SFHBB franchit le seul des 5% du capital de Plant Advanced Technologies PAT
13. Januar 2025 02:00 ET
|
Plant Advanced Technologies
Paris et Vandœuvre-lès-Nancy, le 13 janvier 2025 – 08 : 00 (CET)Communiqué de pressePour diffusion immédiate Franchissement du seuil de 5% Plant Advanced Technologies PAT (Euronext Growth™- Paris -...
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024
23. Dezember 2024 04:00 ET
|
Alvotech
Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI)Inclusion criteria include minimum market capitalization and daily trading volumes REYKJAVIK, Iceland, Dec. 23, 2024 ...
Groupe PAT : PAT participe au projet européen de recherche « Bryomolécules »
16. Dezember 2024 02:00 ET
|
Plant Advanced Technologies
Vandœuvre-lès-Nancy, le 16 décembre 2024 - 08 : 00 (CET) Communiqué de pressePour diffusion immédiate PAT participe au projet européen de recherche « Bryomolécules » Plant Advanced Technologies PAT...
BetterLife Announces Favorable Outcome in New York Legal Claims
09. Dezember 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of...
BetterLife Obtains Favourable Cardiac Safety Data for BETR-001
25. November 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
31. Oktober 2024 07:00 ET
|
SAB Biotherapeutics, Inc.
SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
PAT : Résultats semestriels 2024 non consolidés
30. Oktober 2024 13:51 ET
|
Plant Advanced Technologies
Vandœuvre-lès-Nancy, le 30 octobre 2024 - 18 : 00 (CET) Communiqué de presse Pour diffusion immédiate Résultats semestriels 2024 de PATnon consolidés Résultats au 30 juin 2024 bénéficiaires...
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
30. Oktober 2024 08:30 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first nine months of...